CoChat

Discovery of Cyclic Acylguanidines as Highly Potent and Selective β-Site Amyloid Cleaving Enzyme (BACE) Inhibitors: Part I—Inhibitor Design and Validation

Open access
Zhu, Zhaoning, Sun, Zhong-Yue, Ye, Yuanzan, Voigt, Johannes, Strickland, Corey, Smith, Elizabeth M., Cumming, Jared, Wang, Lingyan, Wong, Jesse, Wang, Yu-Sen, Wyss, Daniel F., Chen, Xia, Kuvelkar, Reshma, Kennedy, Matthew E., Favreau, Leonard, Parker, Eric, McKittrick, Brian A., Stamford, Andrew, Czarniecki, Michael, Greenlee, William, Hunter, John C. · 2010 · Journal of Medicinal Chemistry
Cited by 121

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

A number of novel amidine containing heterocycles were designed to reproduce the unique interaction pattern, revealed by X-ray crystallography, between the BACE-1 catalytic diad and a weak NMR screening hit (3), with special attention paid to maintaining the appropriate basicity and limiting the number of H-bonding donors of these scaffolds. The iminohydantoin cores (10 and 23) were examined first and found to interact with the catalytic diad in one of two binding modes (A and B), each with the iminohydantoin core flipped 180 degrees in relation to the other. The amidine structural motif within each core forms a bidentate interaction with a different aspartic acid of the catalytic diad. Both modes reproduced a highly conserved interaction pattern between the inhibitors and the catalytic aspartates, as revealed by 3. Potent iminohydantoin BACE-1 inhibitors have been obtained, validating the molecular design as aspartyl protease catalytic site inhibitors. Brain penetrant small molecule BACE inhibitors with high ligand efficiencies have been discovered, enabling multiple strategies for further development of these inhibitors into highly potent, selective and in vivo efficacious BACE inhibitors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/jm901408p

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 121

Metadata

Authors
Zhu, Z., Sun, Z.-Y., Ye, Y., Voigt, J., Strickland, C., Smith, E. M., Cumming, J., Wang, L., Wong, J., Wang, Y.-S., Wyss, D. F., Chen, X., Kuvelkar, R., Kennedy, M. E., Favreau, L., Parker, E., McKittrick, B. A., Stamford, A., Czarniecki, M., Greenlee, W., & Hunter, J. C.
Venue
Journal of Medicinal Chemistry
Published
2009-12-31
Volume
53
Issue
3
Pages
951-965
ISSN
  • 0022-2623 (ISSN-L)
  • 1520-4804
OpenAlex
W2045391529
Cited by
121
References
11
FWCI
6.30
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Discovery of Cyclic Acylguanidines as Highly Potent and Selective β-Site Amyloid Cleaving Enzyme (BACE) Inhibitors: Part I—Inhibitor Design and Validation. https://app.cochat.ai/papers/10.1021/jm901408p
The paper
Zhu, Z., Sun, Z.-Y., Ye, Y., Voigt, J., Strickland, C., Smith, E. M., Cumming, J., Wang, L., Wong, J., Wang, Y.-S., Wyss, D. F., Chen, X., Kuvelkar, R., Kennedy, M. E., Favreau, L., Parker, E., McKittrick, B. A., Stamford, A., Czarniecki, M., . . . Hunter, J. C. (2010). Discovery of Cyclic Acylguanidines as Highly Potent and Selective β-Site Amyloid Cleaving Enzyme (BACE) Inhibitors: Part I—Inhibitor Design and Validation. Journal of Medicinal Chemistry. https://doi.org/10.1021/jm901408p

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.